Othon Iliopoulos, MD, PhD

Associate Professor of Medicine at Massachusetts General Hospital Cancer Center, Harvard University Medical Center, USA

Speaker

Othon Iliopoulos is an oncologist at Massachusetts General Hospital, where he serves as the Clinical Director of the VHL Disease/Familial Renal Cell Cancer Program. He is also an Associate Professor of Medicine at Harvard Medical School and at the Center for Cancer Research at MGH. Dr. Iliopoulos is a VHL Alliance Research Grant Recipient and is a Clinical Investigator for the MK-6482 (formerly PT-2977) clinical trial. His lab is involved in research pertaining to the main mechanisms underlying the reprogramming of cancer cell metabolism and cancer angiogenesis with the goal to develop mechanism-based strategies for selectively killing cancer cells. Dr. Iliopoulos is the Chair of the Clinical Advisory Council and the Research Council.